-
Mashup Score: 2Support my fundraising for ResearcHERS: Women Fighting Cancer of Greater Philadelphia - 2 year(s) ago
I’m supporting the American Cancer Society to honor those touched by cancer by raising funds for groundbreaking research. Support me.
Source: secure.acsevents.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors Implications for Current Practice - The ASCO Post - 2 year(s) ago
The rising incidence and prevalence of gastroenteropancreatic endocrine tumors make them the second-most prevalent gastrointestinal cancer.1 Although most of these tumors are relatively slow growing, their histologic grade and differentiation are closely correlated with their clinical behavior.2,3 Most guidelines…
Source: ascopost.comCategories: Latest Headlines, Oncologists2Tweet-
“.. peptide receptor radionuclide therapy has taken center stage in the management of neuroendocrine neoplasms.... -Namrata Vijayvergia, MD, FACP, and Pamela L. Kunz, MD" https://t.co/ouz6H3CV9Q Thank you @ASCOPost and @PamelaKunzMD for the opportunity
-
-
Mashup Score: 5Epigenetics Symposium: From Genes to Chromatin to Therapeutics - 2 year(s) ago
Schedule Program: 8:30 AM – 5:30 PM Reception: 5:30 PM – 7:00 PM
Source: www.foxchase.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CeiFccc: All welcome so register here: https://t.co/PsdHCm1ceS Free @CeiFccc @FoxChaseCancer hosted #Epigenetics hybrid #symposium w/…
-
-
Mashup Score: 0Combating Structural Inequities — Diversity, Equity, and Inclusion in Clinical and Translational Research | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — Combating Structural Inequities — Diversity, Equity, and Inclusion in Clinical and Translational Research
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
@PamelaKunzMD @mpalta1098 @KarynAGoodman @rachnatshroff @NataliyaUboha @KristenCiombor @aparna1024 You just hit the nail there. This article in NEJM should be distributed to all sponsors and clinical trial developers https://t.co/OkL3V1DESh
-
-
Mashup Score: 4Faculty Position - Philadelphia, Pennsylvania (US) job with Fox Chase Cancer Center | 573891 - 2 year(s) ago
CANCER EPIGENETICS
Source: Science CareersCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CeiFccc: https://t.co/IJc6X25DpO Share with anyone that is interested. # Cancer #Epigenetics #Faculty #Positions @FoxChaseCancer @CeiFc…
-
-
Mashup Score: 1Why Wear a Mask?—Explaining Medical Masking to Children - 2 year(s) ago
This Patient Page describes how children should use masks, how to explain the importance of mask wearing, and why it is important for children to wear masks.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The trick worked for my kiddo #MaskUp Why Wear a Mask?—Explaining Medical Masking to Children https://t.co/itKS0VCYkE
-
-
Mashup Score: 0Together Facing Neuroendocrine Tumors [Facebook] - 2 year(s) ago
At Fox Chase Cancer Center, we understand that patients have concerns and questions as they navigate the cancer journey in these challenging times. Join us at facebook.com/foxchasecancercenter for a discussion.
Source: www.foxchase.orgCategories: Latest Headlines, Oncologists2Tweet-
Link to register https://t.co/c7DScJQxal
-
-
Mashup Score: 17
Women Leaders in Oncology has named Pamela Kunz, MD, the 2021 Woman Oncologist of the Year. Dr. Kunz is Associate Professor of Medicine (Medical Oncology), Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center, Chief of GI Medical Oncology, and Vice Chief, Diversity Equity…
Source: ascopost.comCategories: Latest Headlines, Oncologists2Tweet-
RT @ASCOPost: Pamela Kunz, MD, Named 2021 Woman Oncologist of the Year https://t.co/MgSh3eOn7L @PamelaKunzMD @SmilowCancer @WeAreWLO https:…
-
-
Mashup Score: 2
CRANBURY, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a company focused on the growing field of…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Oncologists2Tweet-
Unfortunately another negative study in pancreas. #PancChat @ShaalanBeg @efratdotan https://t.co/OYGmCTvrir
-
-
Mashup Score: 7
Neoadjuvant toripalimab with or without celecoxib could be a potential therapeutic option for patients with mismatch repair deficient or microsatellite instability-high, locally advanced, colorectal cancer. This treatment was associated with a high pathological complete response rate and an acceptable safety profile, which did not compromise surgery. Longer term follow-up is needed to assess…
Categories: Latest Headlines, Oncologists2Tweet-
Neoadjuvant #pd1 therapy in #crc looks pretty promising I’d say… @jeffreyfarma @efratdotan @KristenCiombor @DocDustyD @pashtoonkasi @doctormikehall @CathyEngMD @GIcancerDoc https://t.co/tGq2KhcFev
-
Let’s shine a light on the important discoveries made by #WomenInSTEM and continue to put amazing women at the forefront of cancer research. @AmericanCancer kickstarted my career too. Visit My campaign and help raise funds at https://t.co/vDMhU2mvm5 @FoxChaseCancer https://t.co/6wIswmJPvl